For example, in SCLC, the EZH2 inhibitor GSK126 reduces platinum and etoposide resistance induced by chromodomain Y-like (CDYL) through inhibiting CDKN1C (70). The gene discussed is CDKN1C; the disease is small cell lung carcinoma.